EIKONOKLASTES THERAPEUTICS
Eikonoklastes is advancing a new generation of tissue factor (TF) immunotherapies – therapeutics designed to target the cell surface receptor now known to be prevalent on key components of the tumor microenvironment. It has recently been discovered that certain pathological cells – but not healthy cells – including cancers with high unmet need and high mortality such as triple-negative breast cancer, ovarian cancer, metastatic melanoma, and a broad range of other solid tumors, express tissue factor on the surface of their cell membranes. Several other non-cancerous indications such as endometriosis also highly and selectively express tissue factor.
EIKONOKLASTES THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Life Science
Founded:
2019-01-01
Address:
Cincinnati, Ohio, United States
Country:
United States
Website Url:
http://www.eikonoklastes.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
5.98 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Umoja Biopharma
Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.
Current Employees Featured
Founder
Investors List
Rev1 Ventures
Rev1 Ventures investment in Series A - Eikonoklastes Therapeutics
JobsOhio
JobsOhio investment in Series A - Eikonoklastes Therapeutics
Elk Capital Ventures
Elk Capital Ventures investment in Series A - Eikonoklastes Therapeutics
CincyTech
CincyTech investment in Series A - Eikonoklastes Therapeutics
CincyTech
CincyTech investment in Seed Round - Eikonoklastes Therapeutics
Official Site Inspections
http://www.eikonoklastes.com
- Host name: 4.139.71.34.bc.googleusercontent.com
- IP address: 34.71.139.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Eikonoklastes Therapeutics"
Home - Eikonoklastes
Eikonoklastes Therapeutics, a preclinical biotech company developing treatments for today’s most challenging diseases, and Forge Biologics, a gene therapy-focused contract development and …See details»
Eikonoklastes Therapeutics - Crunchbase Company Profile
Eikonoklastes Therapeutics closed its last funding round on May 6, 2021 from a Series A round. Who are Eikonoklastes Therapeutics 's competitors? Alternatives and possible competitors to …See details»
Eikonoklastes Therapeutics, Inc. | LinkedIn
Eikonoklastes Therapeutics is an early stage biopharmaceutical company focused on rapidly advancing innovative medicines for numerous areas of significant unmet clinical need, starting …See details»
Eikonoklastes Therapeutics, Inc. - Drug pipelines, Patents, Clinical ...
About Eikonoklastes Therapeutics Eikonoklastes Therapeutics is a preclinical biotech company rapidly developing a pipeline of disruptive new treatments for today’s most challenging …See details»
Eikonoklastes Therapeutics and Forge Biologics Announce Viral …
Nov 29, 2022 Eikonoklastes Therapeutics is a preclinical biotech company rapidly developing a pipeline of disruptive new treatments for today’s most challenging diseases. The company’s …See details»
Eikonoklastes Therapeutics - PitchBook
Is Eikonoklastes Therapeutics a private or public company? Eikonoklastes Therapeutics is a Private company. What is Eikonoklastes Therapeutics’s current revenue? The current revenue …See details»
Eikonoklastes Therapeutics Company Profile - Craft
Eikonoklastes Therapeutics is a developer of tissue factor (TF) immunotherapies for triple-negative breast cancer (TNBC) and several other diseases. Its immunotherapies target tissue …See details»
Eikonoklastes Therapeutics, Inc. | Ohio Life Sciences
Eikonoklastes is an early stage biopharmaceutical company focused on rapidly advancing innovative medicines for numerous areas of significant unmet medical need, starting with …See details»
Eikonoklastes Therapeutics - Funding, Financials, Valuation
Eikonoklastes Therapeutics is funded by 4 investors. Rev1 Ventures and JobsOhio are the most recent investors. Unlock for free . Funding Rounds. ... How much funding has this organization …See details»
Eikonoklastes Therapeutics - Products, Competitors, Financials ...
Eikonoklastes Therapeutics operates as a biopharmaceutical company that focuses on developing innovative medicines for areas of unmet medical need, particularly …See details»
Eikonoklastes - VentureRadar
Eikonoklastes Therapeutics is advancing a new generation of tissue factor (TF) immunotherapies for the treatment of triple-negative breast cancer and other cancers and diseases with high …See details»
Eikonoklastes Closes Oversubscribed Series A Financing, Helping …
Jun 28, 2021 Eikonoklastes Therapeutics was founded and is led by a management team with longstanding experience of successful drug development. Working with The Ohio State …See details»
eikonoklastes.com Reviews: Is this site a scam or legit?
Is eikonoklastes.com legit, safe, or a scam? While the website received a medium-high score, you need to read the details below before engaging in any business. We put to work 53 powerful …See details»
Eikonoklastes Bolsters Pipeline, Announces a License for Novel …
Jan 19, 2022 Tom Finn, Eikonoklastes Board Member and former President of P&G Global Health Care, said the novel therapy represents a continuation of the company’s efforts to …See details»
Eikonoklastes - Wikipedia
Title page of Eikonoklastes.. Eikonoklastes (from the Greek εἰκονοκλάστης, "iconoclast") is a book by John Milton, published October 1649.In it he provides a justification for the execution of …See details»
Eikonoklastes | work by Milton | Britannica
Other articles where Eikonoklastes is discussed: John Milton: Antimonarchical tracts: In his rebuttal, Eikonoklastes (1649; “Image-Breaker”), Milton shatters the image of the king …See details»
Eikonoklastes: Introduction - Dartmouth
Introduction. Composing Eikonoklastes was one of the first assignments John Milton undertook as Secretary for Foreign Languages to Oliver Cromwell's Council of State. He published The …See details»
Eikonoklastes, 1649 : John Geraghty : Free Download, Borrow, and ...
Aug 6, 2013 Eikonoklastes, 1649 by John Geraghty. Topics Eikonoklastes, John Milton, 1649, English Civil War, regicide Collection opensource Item Size 163.2M . John Milton …See details»
Spiritual Reading in Milton's 'Eikonoklastes' - JSTOR
158 Milton's Eikonoklastes his text. In Eikonoklastes, Milton pursues purposes beyond the merely propagandistic, and his work is particularly successful as a demonstration of critical and …See details»
Eikonoklastes : in answer to a book intitl'd Eikon basilike : the ...
Eikonoklastes : in answer to a book intitl'd Eikon basilike : the portrature of his Sacred Majesty in his solitudes and sufferings / the author I[ohn]. M[ilton] by Milton, John, 1608-1674; Simons, …See details»